On October 16, 2025, INVO Fertility, Inc. announced that an investor exercised a right to purchase 500 shares of Series C-2 Convertible Preferred Stock for $500,000, adjusting the conversion price to $0.6285 per share. This filing is categorized under 'Changes in capital structure'.